[Tamoxifen as a suppressor of mammary carcinogenesis induced by 7,12-dimethyl-benzanthracene and methylnitrosourea, in female rats with induced hyperprolactinemia].
D015127:9,10-Dimethyl-1,2-benzanthracene / Q000009:adverse effects*; D000818:Animals; D001943:Breast Neoplasms / Q000139:chemically induced / Q000188:drug therapy*; D005260:Female; D008770:Methylnitrosourea / Q000009:adverse effects*; D009607:Nitrosourea Compounds / Q000009:adverse effects*; D011388:Prolactin / Q000378:metabolism*; D051381:Rats; D013469:Sulpiride / Q000494:pharmacology; D013629:Tamoxifen / Q000627:therapeutic use*
D009607:Nitrosourea Compounds; D013629:Tamoxifen; D015127:9,10-Dimethyl-1,2-benzanthracene; D008770:Methylnitrosourea; D013469:Sulpiride; D011388:Prolactin
Tamoxifeno como supresor de la carcinogenesis mamaria inducida por 7,12-dimetil-benzoantraceno y nitroso-metilurea, en ratas hembras con hiperprolactinemia provocada.